Found 67 results
Author Title Type [ Year(Asc)]
Filters: Author is Van Veldhuisen, P  [Clear All Filters]
2000
J. Copley, Staffeld, C., Lindberg, J., Bailey, C., and Van Veldhuisen, P., Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks, 2000.
P. Martin, Crippin, J., Goldstein, R. M., Artinian, L., Van Veldhuisen, P., Klintmalm, G. D., and Busuttil, R. W., Primary immunosuppressive agent does not affect Hepatitis C recurrence rates following liver transplantation, 2000.
C. Johnson, Ahsan, N., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W. E., Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation., Transplantation, vol. 69, no. 5, pp. 834-41, 2000.
C. Johnson, Ahsan, N., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, III, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W. E., Randomized trial of tacrolimus (PROGRAF™) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation, Transplantation, vol. 69, pp. 834-41, 2000.
T. A. Gonwa, Johnson, C., Ahsan, N., ,, Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., Scotellaro, P., and Fitzsimmons, W., Untitled, 2000.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Risso, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., The use of monoclonal therapy in the treatment of intraocular inflammatory disease, 2000.
1999
T. Gonwa, Ahsan, N., Halloran, P., Stegal, M., Hardy, M., Metzgar, R., Shield, III, C., Rocher, L., Scandling, J., Sorensen, L., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W., Comparative trial of Prograf™ (tacrolimus) in combination with azathiprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofeitil after kidney transplantation, 1999.
J. Copley, Staffeld, C., Lindberg, J., Baily, C., and Van Veldhuisen, P., The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity, 1999.
C. O. Taylor, Barr, M. L., Radovancevic, B., Renlund, D. G., Mentzer, Jr., R. M., Smart, F. W., Tolman, D. E., Frazier, O. H., Young, J. B., and Van Veldhuisen, P., A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardia transplantation: decreased hyperlipidemia and hypertension with tacrolimus, J Heart Lung Transplant, vol. 18, pp. 336-345, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial., Proc Natl Acad Sci U S A, vol. 96, no. 13, pp. 7462-6, 1999.